These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6278660

  • 1. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J, Ruiz Puente J, González Pacheco M.
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract] [Full Text] [Related]

  • 2. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J, Rivera Rivera D, González Pacheco M.
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract] [Full Text] [Related]

  • 3. Morphological alterations of the adrenal gland following administration of histamine-sensitizing-factor of Bordetella pertussis.
    Kuwajima Y.
    Osaka City Med J; 1980; 26(1):61-6. PubMed ID: 6267538
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between growth rate and loss of histamine-sensitizing factor during antigenic modulation in Bordetella pertussis.
    Idigbe EO.
    Microbios; 1987; 49(199):79-89. PubMed ID: 2883559
    [Abstract] [Full Text] [Related]

  • 5. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
    Smirnov VD, Chuprinina RP, Siundiukova RA, Maksiutov RV.
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
    [Abstract] [Full Text] [Related]

  • 6. Histamine-sensitizing factor of Alcaligenes faecalis.
    Simmons DG, Rose LP, McCorkle FM, Luginbuhl GH.
    Avian Dis; 1983 Mar; 27(1):171-7. PubMed ID: 6682654
    [Abstract] [Full Text] [Related]

  • 7. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE, Broderick EJ, Levine L.
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract] [Full Text] [Related]

  • 8. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J, Ocklitz HW.
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract] [Full Text] [Related]

  • 9. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y, Arai H.
    Tanpakushitsu Kakusan Koso; 1972 Mar; 17(2):139-49. PubMed ID: 4337077
    [No Abstract] [Full Text] [Related]

  • 10. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA.
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [Abstract] [Full Text] [Related]

  • 11. Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium.
    Idigbe EO, Parton R, Wardlaw AC.
    J Med Microbiol; 1981 Nov; 14(4):409-18. PubMed ID: 6273564
    [Abstract] [Full Text] [Related]

  • 12. Removal of lipopolysaccharide from acellular Bordetella pertussis vaccine by detergent treatment.
    Stinson RS, Lemmon RD, Baggett DW, Huff TL, Malone JA, Sloan GL, Winters AL.
    J Biol Stand; 1986 Oct; 14(4):261-71. PubMed ID: 2881930
    [Abstract] [Full Text] [Related]

  • 13. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM, Lustigman B.
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [Abstract] [Full Text] [Related]

  • 14. The purification and characterization of an acellular pertussis vaccine.
    Chazono M, Yoshida I, Konobe T, Fukai K.
    J Biol Stand; 1988 Apr; 16(2):83-9. PubMed ID: 2897370
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
    Ben-Nun A, Mendel I, Kerlero de Rosbo N.
    Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
    [Abstract] [Full Text] [Related]

  • 16. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN.
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [Abstract] [Full Text] [Related]

  • 17. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A, Hawkins DC.
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [Abstract] [Full Text] [Related]

  • 18. [Immunobiological properties of Bordetella pertussis].
    Kopacka B.
    Pediatr Pol; 1972 Feb; 47(3):361-70. PubMed ID: 4336329
    [No Abstract] [Full Text] [Related]

  • 19. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP, Dolby JM.
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract] [Full Text] [Related]

  • 20. Interconnexion between the protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    JOO I, PUSZTAI Z.
    Nature; 1960 Oct 22; 188():331-2. PubMed ID: 13790658
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.